Based in Dallas and Nashville, Pharos Capital Group has approximately $750 million in capital under management through three private equity funds. Our latest partnership is a $535 million fund focused on providing later stage equity funding for internal growth, acquisitions, leveraged buyouts, manag…
Based in Dallas and Nashville, Pharos Capital Group has approximately $750 million in capital under management through three private equity funds. Our latest partnership is a $535 million fund focused on providing later stage equity funding for internal growth, acquisitions, leveraged buyouts, management buyouts or recapitalizations across industry sectors, with particular focus on healthcare.
Pharos is primarily seeking to provide capital to established healthcare companies based in the United States.
Our investment preferences include the following:
Funding for acquisitions, leveraged buyouts, management buyouts, and recapitalizations of cash flowing businesses.
Revenue of at least $10 million. EBITDA of at least $2 million. Growth rate of 20% or more, either organically or via acquisition. Investment size of $20 to $50 million per platform company. Emphasis on undercapitalized businesses in underserved regions across the nation.
Within the healthcare sector, we focus on the following sub-groups:
High quality, outcomes focused healthcare providers Managed care services Behavioral health Wellness, disease and/or population management Diagnostic technology and services Medical device companies with FDA approved technology Healthcare data analytics and outcomes measurement Telemedicine Other companies serving the healthcare sector
When evaluating an investment opportunity, we also consider the following criteria:
We seek to make investments in healthcare companies that improve the patient experience of care (including quality and satisfaction), reduce the total cost of health care, and possess attractive growth prospects either internally through core revenue growth or externally through acquisitions.
Conversely, we do not target investments in companies in the drug development, life sciences, and biotechnology sectors, due to the long development cycle necessary before they typically generate significant revenue.
We look to back companies with professional management teams whether that be the existing team, our stable of proven Healthcare Operating Partners, or a combination of both.
We prefer portfolio companies that offer multiple exit opportunities. These exit strategies may involve a financial buyer, an initial public offering, a recapitalization or a sale to a strategic purchaser.
We tailor the deal structure of each investment to meet the risk and return objectives of the Partnership while striking the appropriate balance with the needs of the entrepreneur and existing shareholder.
We target companies that have defensible market positions, sustainable competitive advantage and unique attributes to their business model
Health Care Services, Medical Equipment and Supplies Manufacturing, Medical glassware made from purchased glass, Medical glassware made in glass making plants
acquired
Vantage Surgical Solutions
September 2021
Pharos Capital Group
Health Care Services
acquired
Charter Health Care Group
August 2021
Pharos Capital Group
Health Care Services, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
Health Care Services, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
acquired
The Family Treatment Network
October 2016
Pharos Capital Group
Drugs and Druggists' Sundries Distributors (Wholesalers), Healthcare Software (Consumer), Healthcare Software (Enterprise), Medical Equipment and Supplies Manufacturing, Medical glassware made from purchased glass, Medical glassware made in glass making plants, Medical, Dental, and Hospital Equipment and Supplies Distributors (Wholesalers), Ophthalmic Goods Distributors (Wholesalers)
acquired
TechLab
September 2016
Pharos Capital Group
Health Care Services, HMO Medical Centers
acquired
FasPsych
August 2016
Pharos Capital Group
Health Care Services, HMO Medical Centers, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
acquired
MOTION Physical Therapy Group
June 2016
Pharos Capital Group
Health Care Services, HMO Medical Centers, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
acquired
Beacon Specialized Living Services, Inc.
May 2016
Pharos Capital Group
Health Care Services, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
acquired
Sona Dermatology & MedSpa
January 2016
Pharos Capital Group
Health Care Services
acquired
Employee Benefit Solutions
May 2014
Pharos Capital Group
Health Care Services, HMO Medical Centers, Hospitals, Nursing and Residential Care Facilities, Veterinary Services
acquired
Seaside Healthcare
December 2013
Pharos Capital Group
acquired
Egenera, Inc.
October 2010
Pharos Capital Group
acquired
Alereon, Inc.
October 2010
Pharos Capital Group
acquired
American Beacon Advisors
October 2010
Pharos Capital Group
acquired
Pioneer Surgical Technology, Inc.
October 2010
Pharos Capital Group
acquired
Reel FX, Inc.
October 2010
Pharos Capital Group
acquired
Time Domain Corporation
October 2010
Pharos Capital Group
acquired
Travel Holdings, Inc.
October 2010
Pharos Capital Group
Health Care Services
acquired
Windsor Health Group
August 2005
Pharos Capital Group
Health Care Services
acquired
Atherotech Inc.
August 2002
Sectors Pharos Capital Group serves:
Business Services
Technology
Health Care
Distribution
Industrials
Retail
Consumer Goods
Consumer Services
Life Sciences
Join Axial's Private M&A Platform
Pharos Capital Group connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.